17754-44-8C=C1[C@@H]2CC[C@H]3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@H]1O.[K+].[K+]IUCNQFHEWLYECJ-FNAJZLPOSA-LAtractyloside is an organic molecular entity.
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Danger
H301+H311+H331 (100%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
atractyloside
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
17754-44-8DTXSID201339886CHEMBL499815CHEBI:2913